BlackRock’s enVVeno Medical NVNO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $229K | Buy |
57,404
+17,275
| +43% | +$68.9K | ﹤0.01% | 4562 |
|
2025
Q1 | $106K | Sell |
40,129
-495
| -1% | -$1.3K | ﹤0.01% | 4709 |
|
2024
Q4 | $123K | Buy |
40,624
+165
| +0.4% | +$498 | ﹤0.01% | 4683 |
|
2024
Q3 | $136K | Buy |
40,459
+990
| +3% | +$3.33K | ﹤0.01% | 4561 |
|
2024
Q2 | $207K | Buy |
39,469
+1,978
| +5% | +$10.4K | ﹤0.01% | 4490 |
|
2024
Q1 | $204K | Sell |
37,491
-650
| -2% | -$3.54K | ﹤0.01% | 4512 |
|
2023
Q4 | $196K | Buy |
38,141
+7,062
| +23% | +$36.3K | ﹤0.01% | 4568 |
|
2023
Q3 | $168K | Sell |
31,079
-2,624
| -8% | -$14.1K | ﹤0.01% | 4657 |
|
2023
Q2 | $104K | Sell |
33,703
-749
| -2% | -$2.31K | ﹤0.01% | 4810 |
|
2023
Q1 | $161K | Buy |
34,452
+642
| +2% | +$3.01K | ﹤0.01% | 4749 |
|
2022
Q4 | $172K | Buy |
33,810
+146
| +0.4% | +$745 | ﹤0.01% | 4807 |
|
2022
Q3 | $211K | Buy |
33,664
+254
| +0.8% | +$1.59K | ﹤0.01% | 4873 |
|
2022
Q2 | $127K | Sell |
33,410
-5,031
| -13% | -$19.1K | ﹤0.01% | 5075 |
|
2022
Q1 | $244K | Buy |
38,441
+1,078
| +3% | +$6.84K | ﹤0.01% | 4970 |
|
2021
Q4 | $246K | Buy |
37,363
+18,229
| +95% | +$120K | ﹤0.01% | 4989 |
|
2021
Q3 | $199K | Sell |
19,134
-3,296
| -15% | -$34.3K | ﹤0.01% | 4926 |
|
2021
Q2 | $154K | Buy |
+22,430
| New | +$154K | ﹤0.01% | 4882 |
|